Hi RED,
I found it interesting when reading the Japanese patent approval that the mode of activity of RCE 327 & 529 are as stated:
"Use of R327 or R529 for the treatment of viruses having a lipid envelope or coat, examples being SARS-CoV-2 and corona viruses, influenza viruses, HIV, hepatitis, Ross River and Herpes viruses".
Therefore one might assume that RCE is a lipopeptide material - maybe someone else with a more bio-chemical nouse can answer this for us...
Rgds
DW
Hi RED,I found it interesting when reading the Japanese patent...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $131.5M | |||
| Open | High | Low | Value | Volume |
| 66.0¢ | 66.0¢ | 64.0¢ | $31.74K | 49.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24674 | 63.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.5¢ | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
65.0¢ |
Change
0.000 ( 0.53 %) |
||||
| Open | High | Low | Volume | ||
| 64.5¢ | 65.0¢ | 64.0¢ | 5994 | ||
| Last updated 11.57am 03/05/2024 ? | |||||
| RCE (ASX) Chart |